Suppr超能文献

COVID-19 中先天免疫和适应性免疫反应相互作用的数学建模及其对病毒发病机制的影响。

Mathematical modeling of interaction between innate and adaptive immune responses in COVID-19 and implications for viral pathogenesis.

机构信息

Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California.

出版信息

J Med Virol. 2020 Sep;92(9):1615-1628. doi: 10.1002/jmv.25866. Epub 2020 May 13.

Abstract

We have applied mathematical modeling to investigate the infections of the ongoing coronavirus disease-2019 (COVID-19) pandemic caused by SARS-CoV-2 virus. We first validated our model using the well-studied influenza viruses and then compared the pathogenesis processes between the two viruses. The interaction between host innate and adaptive immune responses was found to be a potential cause for the higher severity and mortality in COVID-19 patients. Specifically, the timing mismatch between the two immune responses has a major impact on disease progression. The adaptive immune response of the COVID-19 patients is more likely to come before the peak of viral load, while the opposite is true for influenza patients. This difference in timing causes delayed depletion of vulnerable epithelial cells in the lungs in COVID-19 patients while enhancing viral clearance in influenza patients. Stronger adaptive immunity in COVID-19 patients can potentially lead to longer recovery time and more severe secondary complications. Based on our analysis, delaying the onset of adaptive immune responses during the early phase of infections may be a potential treatment option for high-risk COVID-19 patients. Suppressing the adaptive immune response temporarily and avoiding its interference with the innate immune response may allow the innate immunity to more efficiently clear the virus.

摘要

我们应用数学模型来研究由 SARS-CoV-2 病毒引起的正在进行的 2019 年冠状病毒病(COVID-19)大流行的感染情况。我们首先使用研究充分的流感病毒对模型进行了验证,然后比较了两种病毒的发病机制过程。宿主固有和适应性免疫反应之间的相互作用被认为是 COVID-19 患者病情更严重和死亡率更高的潜在原因。具体而言,两种免疫反应之间的时间不匹配对疾病进展有重大影响。COVID-19 患者的适应性免疫反应更有可能在病毒载量达到峰值之前出现,而流感患者则相反。这种时间上的差异导致 COVID-19 患者肺部易受伤害的上皮细胞耗竭延迟,而流感患者的病毒清除增强。COVID-19 患者更强的适应性免疫反应可能导致更长的恢复时间和更严重的继发性并发症。基于我们的分析,在感染的早期阶段延迟适应性免疫反应的开始可能是高危 COVID-19 患者的一种潜在治疗选择。暂时抑制适应性免疫反应并避免其与固有免疫反应相互干扰,可以使固有免疫更有效地清除病毒。

相似文献

3
Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments.
Viruses. 2021 Jun 14;13(6):1141. doi: 10.3390/v13061141.
4
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9.
6
Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
Int Rev Immunol. 2021;40(1-2):108-125. doi: 10.1080/08830185.2020.1844195. Epub 2020 Nov 16.
7
Innate immunity in COVID-19: Drivers of pathogenesis and potential therapeutic targets.
Asian Pac J Allergy Immunol. 2021 Jun;39(2):69-77. doi: 10.12932/AP-130121-1037.
8
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities.
Semin Immunol. 2021 Jun;55:101522. doi: 10.1016/j.smim.2021.101522. Epub 2021 Nov 9.
9
How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era.
Front Immunol. 2021 Mar 29;12:666983. doi: 10.3389/fimmu.2021.666983. eCollection 2021.
10
The Immune Responses against Coronavirus Infections: Friend or Foe?
Int Arch Allergy Immunol. 2021;182(9):863-876. doi: 10.1159/000516038. Epub 2021 May 5.

引用本文的文献

1
Immune modulation: the key to combat SARS-CoV-2 induced myocardial injury.
Front Immunol. 2025 May 14;16:1561946. doi: 10.3389/fimmu.2025.1561946. eCollection 2025.
3
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations.
Front Immunol. 2025 Jan 31;16:1510770. doi: 10.3389/fimmu.2025.1510770. eCollection 2025.
4
A biomathematical model of SARS-CoV-2 in Syrian hamsters.
Sci Rep. 2024 Dec 18;14(1):30541. doi: 10.1038/s41598-024-80498-9.
5
Stability of a discrete HTLV-1/SARS-CoV-2 dual infection model.
Heliyon. 2024 Mar 18;10(7):e28178. doi: 10.1016/j.heliyon.2024.e28178. eCollection 2024 Apr 15.
6
The kinetics of SARS-CoV-2 infection based on a human challenge study.
Proc Natl Acad Sci U S A. 2024 Nov 12;121(46):e2406303121. doi: 10.1073/pnas.2406303121. Epub 2024 Nov 7.
7
Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment.
Front Immunol. 2024 Aug 9;15:1329162. doi: 10.3389/fimmu.2024.1329162. eCollection 2024.
8
A stochastic approach for co-evolution process of virus and human immune system.
Sci Rep. 2024 May 6;14(1):10337. doi: 10.1038/s41598-024-60911-z.
9
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
PLoS Pathog. 2024 Apr 18;20(4):e1011680. doi: 10.1371/journal.ppat.1011680. eCollection 2024 Apr.
10
COVID-19 dynamics and immune response: Linking within-host and between-host dynamics.
Chaos Solitons Fractals. 2023 Jun 26:113722. doi: 10.1016/j.chaos.2023.113722.

本文引用的文献

1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
4
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.
Sci China Life Sci. 2020 Mar;63(3):457-460. doi: 10.1007/s11427-020-1637-5. Epub 2020 Jan 21.
5
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
6
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.
N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
8
Effects of Antirejection Drugs on Innate Immune Cells After Kidney Transplantation.
Front Immunol. 2019 Dec 19;10:2978. doi: 10.3389/fimmu.2019.02978. eCollection 2019.
10
Regeneration of the Aging Lung: A Mini-Review.
Gerontology. 2017;63(3):270-280. doi: 10.1159/000451081. Epub 2016 Nov 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验